Vaccine specialist Valneva has picked up an ... s third quarter and is the only approved HIF-2α inhibitor in the U.S. Merck’s application in PPGL is based on objective response rate and ...

If you had any doubt about the “vibe shift” in 2025 Washington, look no further than the impact the Make America Healthy ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But ...